Analysis of the original tumor tissue revealed a range of molecular alterations, with chromosomal aberrations and mutations (Fig 1C) as well as marked interpatient variability in the expression of EGFR, PDGFR, p53, and MIB-1 (Fig 1D) in immunohistochemical stainings. This evidence concerns the gene TP53 and neoplasm.